A detailed history of Apriem Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Apriem Advisors holds 12,434 shares of ABBV stock, worth $2.24 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
12,434
Previous 12,572 1.1%
Holding current value
$2.24 Million
Previous $2.16 Million 13.87%
% of portfolio
0.29%
Previous 0.26%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $22,609 - $27,507
-138 Reduced 1.1%
12,434 $2.46 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $16,562 - $19,341
-107 Reduced 0.84%
12,572 $2.16 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $2.05 Million - $2.33 Million
-12,797 Reduced 50.23%
12,679 $2.31 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $142,553 - $160,548
-1,036 Reduced 3.91%
25,476 $3.95 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $645,106 - $746,804
-4,829 Reduced 15.41%
26,512 $3.95 Million
Q2 2023

Aug 08, 2023

BUY
$132.51 - $164.9 $895,370 - $1.11 Million
6,757 Added 27.49%
31,341 $4.22 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $1.77 Million - $2.03 Million
12,212 Added 98.71%
24,584 $3.92 Million
Q4 2022

Feb 13, 2023

SELL
$138.31 - $165.87 $51,589 - $61,869
-373 Reduced 2.93%
12,372 $2 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $111,125 - $127,454
-828 Reduced 6.1%
12,745 $1.71 Million
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $77,480 - $98,502
-563 Reduced 3.98%
13,573 $2.08 Million
Q1 2022

May 10, 2022

SELL
$131.98 - $163.75 $118,122 - $146,556
-895 Reduced 5.95%
14,136 $2.29 Million
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $3,974 - $5,029
37 Added 0.25%
15,031 $2.04 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $3,404 - $3,864
32 Added 0.21%
14,994 $1.62 Million
Q2 2021

Aug 10, 2021

BUY
$105.21 - $117.21 $12,835 - $14,299
122 Added 0.82%
14,962 $1.69 Million
Q1 2021

May 10, 2021

SELL
$102.3 - $112.62 $5,115 - $5,631
-50 Reduced 0.34%
14,840 $1.61 Million
Q4 2020

Feb 04, 2021

BUY
$80.49 - $108.67 $47,006 - $63,463
584 Added 4.08%
14,890 $1.6 Million
Q3 2020

Nov 10, 2020

BUY
$85.91 - $100.83 $31,271 - $36,702
364 Added 2.61%
14,306 $1.25 Million
Q2 2020

Aug 07, 2020

BUY
$73.37 - $98.18 $258,555 - $345,986
3,524 Added 33.83%
13,942 $1.37 Million
Q1 2020

May 07, 2020

BUY
$64.5 - $97.79 $9,159 - $13,886
142 Added 1.38%
10,418 $794,000
Q4 2019

Feb 10, 2020

SELL
$72.13 - $90.25 $25,245 - $31,587
-350 Reduced 3.29%
10,276 $910,000
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $5.26 Million - $6.33 Million
-83,540 Reduced 88.72%
10,626 $805,000
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $455,038 - $581,645
6,926 Added 7.94%
94,166 $6.85 Million
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $734,064 - $863,957
9,516 Added 12.24%
87,240 $7.03 Million
Q4 2018

Feb 19, 2019

BUY
$77.85 - $96.01 $533,350 - $657,764
6,851 Added 9.67%
77,724 $7.17 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $16,448 - $18,285
185 Added 0.26%
70,873 $6.7 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $309,741 - $366,493
3,450 Added 5.13%
70,688 $6.55 Million
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $399,875 - $535,470
-4,346 Reduced 6.07%
67,238 $6.36 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $270,471 - $296,594
-3,020 Reduced 4.05%
71,584 $6.92 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $5.21 Million - $6.66 Million
74,604
74,604 $6.63 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Apriem Advisors Portfolio

Follow Apriem Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apriem Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Apriem Advisors with notifications on news.